| Dorothy Shearn, MD | |
|
4300 B St, Suite 200, Anchorage, AK 99503-5925 | |
| (907) 375-3355 | |
| (907) 375-3351 |
| Full Name | Dorothy Shearn |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 30 Years |
| Location | 4300 B St, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275633091 | NPI | - | NPPES |
| MD27011 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4382 (Alaska) | Secondary |
| 208M00000X | Hospitalist | 4382 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Hospitalist Group Llc | 6507755964 | 84 |
News Archive
Global healthcare knowledge provider BMJ has added The Journal of ISAKOS: Joint Disorders & Orthopaedic Sports Medicine (JISAKOS) to its extensive portfolio of specialty journals, the company has announced.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
Breathing dirty air takes a heavy toll on gut bacteria, boosting risk of obesity, diabetes, gastrointestinal disorders and other chronic illnesses, new University of Colorado Boulder research suggests.
SurModics, Inc. announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc., a drug delivery company specializing in injectable, biodegradable sustained release formulations.
The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.
› Verified 2 days ago
| Entity Name | Alaska Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831296995 PECOS PAC ID: 6507755964 Enrollment ID: O20040312001148 |
News Archive
Global healthcare knowledge provider BMJ has added The Journal of ISAKOS: Joint Disorders & Orthopaedic Sports Medicine (JISAKOS) to its extensive portfolio of specialty journals, the company has announced.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
Breathing dirty air takes a heavy toll on gut bacteria, boosting risk of obesity, diabetes, gastrointestinal disorders and other chronic illnesses, new University of Colorado Boulder research suggests.
SurModics, Inc. announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc., a drug delivery company specializing in injectable, biodegradable sustained release formulations.
The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dorothy Shearn, MD 4300 B St, Suite 200, Anchorage, AK 99503-5925 Ph: (907) 375-3355 | Dorothy Shearn, MD 4300 B St, Suite 200, Anchorage, AK 99503-5925 Ph: (907) 375-3355 |
News Archive
Global healthcare knowledge provider BMJ has added The Journal of ISAKOS: Joint Disorders & Orthopaedic Sports Medicine (JISAKOS) to its extensive portfolio of specialty journals, the company has announced.
Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.
Breathing dirty air takes a heavy toll on gut bacteria, boosting risk of obesity, diabetes, gastrointestinal disorders and other chronic illnesses, new University of Colorado Boulder research suggests.
SurModics, Inc. announced today that it has acquired a portfolio of intellectual property and collaborative drug delivery projects from PR Pharmaceuticals, Inc., a drug delivery company specializing in injectable, biodegradable sustained release formulations.
The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.
› Verified 2 days ago
Casey Mapes, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Stephen C Ellison, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Jonathan Daining, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Dr. Heath Wade Turner, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Alisha Alexandra Skinner, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3355 | |
Esther Lee Hargrave, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Larry Scott Owen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 |